Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension

Hitoshi Ogino1, Motomi Ando, Hitoshi Matsuda

  • 1Department of Cardiovascular Surgery, National Cardiovascular Center, Suita, Osaka, Japan. hogino@hsp.ncvc.go.jp

Insights

Pulmonary endarterectomy surgery for chronic thromboembolic pulmonary hypertension (CTEPH) shows favorable long-term survival and low mortality. Careful surgical consideration is advised for patients with distal disease.

Area of Science:

  • Cardiovascular Surgery
  • Pulmonary Hypertension Research

Background:

  • Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe condition.
  • Surgical intervention, specifically pulmonary endarterectomy, is a treatment option for CTEPH.

Purpose of the Study:

  • To review the surgical outcomes for patients with CTEPH.
  • To evaluate the safety, efficacy, and long-term prognosis of pulmonary endarterectomy.

Main Methods:

  • Eighty-eight patients underwent pulmonary endarterectomy between 1995 and 2004.
  • The procedure involved intermittent circulatory arrest and hypothermia.
  • Lesion location (proximal, subsegmental, peripheral) was categorized.

Main Results:

  • Hospital mortality was 8.0%, with pulmonary bleeding and residual hypertension as causes.
  • Survivors showed significant reductions in pulmonary artery pressure and vascular resistance (p < 0.0001).
  • Actuarial survival was 90.7% at 3 years and 86.4% at 5 years; event-free rates were high.

Conclusions:

  • Pulmonary endarterectomy is a safe procedure with low mortality and good long-term survival for CTEPH.
  • Distal disease requires careful surgical management, though it does not significantly increase mortality risk.
  • Most long-term survivors are weaned from oxygen therapy, indicating significant functional improvement.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...